Cargando…
The Effects of Osteoporotic and Non-osteoporotic Medications on Fracture Risk and Bone Mineral Density
Osteoporosis is a highly prevalent bone disease affecting more than 37.5 million individuals in the European Union (EU) and the United States of America (USA). It is characterized by low bone mineral density (BMD), impaired bone quality, and loss of structural and biomechanical properties, resultin...
Autores principales: | van der Burgh, Anna C., de Keyser, Catherine E., Zillikens, M. Carola, Stricker, Bruno H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578161/ https://www.ncbi.nlm.nih.gov/pubmed/34724173 http://dx.doi.org/10.1007/s40265-021-01625-8 |
Ejemplares similares
-
Bone Mineral Density and Risk of Osteoporotic Fractures in Women with Parkinson's Disease
por: Bystrytska, Maryna, et al.
Publicado: (2020) -
Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis
por: Vujasinovic, Miroslav, et al.
Publicado: (2021) -
Relationship between sleep pattern and bone mineral density in
patients with osteoporotic fracture
por: Zeng, Haobin, et al.
Publicado: (2022) -
Effect of gynecological cancer and its treatment on bone mineral density and the risk of osteoporosis and osteoporotic fracture
por: Lee, Jeong Eun, et al.
Publicado: (2020) -
WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk
por: Zheng, Hou-Feng, et al.
Publicado: (2012)